ClearPoint Neuro, Inc. (CLPT) vs Sanara MedTech Inc. (SMTI)

A side-by-side comparison of ClearPoint Neuro, Inc. and Sanara MedTech Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CLPT vs SMTI

growth of $100 · dividends reinvested · last 10y
CLPT +88.9% (+6.6%/yr)SMTI +775.0% (+24.2%/yr)SMTI compounded faster over this window
05001kStart $10020182020202220242026$189$875
CLPT SMTI

CLPT vs SMTI: by the numbers

  • •CLPT is the larger company ($330M vs $322M market cap).
  • •Both run net losses; SMTI's is the smaller (-29.15% vs -81.76% net margin).
  • •SMTI grew revenue faster over the past five years (40.06% vs 23.57% CAGR).

Metrics side by side

Valuation

MetricCLPTSMTI
Forward P/EN/A184.21
P/S ratio7.812.93
P/B ratio30.6440.51
EV / EBITDAN/A27.80
FCF yieldN/A1.40%

Profitability

MetricCLPTSMTI
Gross margin62.61%91.33%
Operating margin-65.36%9.36%
Net margin-81.76%-29.15%
ROE-320.77%-403.03%
ROIC-40.51%18.15%

Growth (annualized)

MetricCLPTSMTI
Revenue CAGR (5Y)23.57%40.06%
Total return CAGR (5Y)-7.65%0.35%

Frequently asked

Which has grown faster, CLPT or SMTI?
Over the past five years, SMTI grew revenue faster — CLPT at a 23.57% CAGR versus SMTI at 40.06%.
How have CLPT and SMTI total returns compared?
Over the past 10 years, CLPT delivered 6.57% and SMTI delivered 24.23% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.